Nehad M. Ayoub

2.4k total citations
72 papers, 1.7k citations indexed

About

Nehad M. Ayoub is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Nehad M. Ayoub has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Nehad M. Ayoub's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Nehad M. Ayoub is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Nehad M. Ayoub collaborates with scholars based in Jordan, United States and Bahrain. Nehad M. Ayoub's co-authors include Mohamed R. Akl, Kamal M. Al-Shami, Paul W. Sylvester, Mohamed M. Mohyeldin, Khalid A. El Sayed, Rami J. Yaghan, K. Stephen Suh, André Goy, Sami Nazzal and Amer E. Alkhalifa and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecules.

In The Last Decade

Nehad M. Ayoub

69 papers receiving 1.6k citations

Peers

Countries citing papers authored by Nehad M. Ayoub

Since Specialization

Citations

This map shows the geographic impact of Nehad M. Ayoub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nehad M. Ayoub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nehad M. Ayoub more than expected).

Fields of papers citing papers by Nehad M. Ayoub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nehad M. Ayoub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nehad M. Ayoub. The network helps show where Nehad M. Ayoub may publish in the future.

Co-authorship network of co-authors of Nehad M. Ayoub

This figure shows the co-authorship network connecting the top 25 collaborators of Nehad M. Ayoub. A scholar is included among the top collaborators of Nehad M. Ayoub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nehad M. Ayoub. Nehad M. Ayoub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer 2024 ·Technology in Cancer Research & Treatment ·(unknown), Nehad M. Ayoub, Ahmed H. Al Sharie, (unknown)	12
2	BRAF Expression and Copy Number Alterations Predict Unfavorable Tumor Features and Adverse Outcomes in Patients With Breast Cancer 2024 ·International Journal of Breast Cancer ·(unknown), Nehad M. Ayoub, (unknown), Aymen Shatnawi, Rami J. Yaghan	2
3	Assessment of satisfaction of attendees of healthcare centers in Jordan with community pharmacy services of pharmacies they usually use 2024 ·PLoS ONE ·(unknown), Nehad M. Ayoub	0
4	A Survey of Knowledge and Barriers of Healthcare Professionals toward Opioid Analgesics in Cancer Pain Management 2022 ·International Journal of Clinical Practice ·Nehad M. Ayoub, (unknown), Khawla Nuseir, (unknown)	7
5	Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches 2022 ·Frontiers in Pharmacology ·Nehad M. Ayoub, (unknown), Kamal M. Al-Shami, Amer E. Alkhalifa	83
6	Organophosphate pesticide exposure prenatally influence on pregnancy outcomes 2021 ·The Journal of Maternal-Fetal & Neonatal Medicine ·Khawla Nuseir, Linda Tahaineh, (unknown), (unknown), Nehad M. Ayoub, Tareq L. Mukattash, Naseer Al-Rawi	2
7	Knowledge and Practice of Breast Cancer Screening Methods among Female Community Pharmacists in Jordan: A Cross-Sectional Study 2021 ·International Journal of Breast Cancer ·Nehad M. Ayoub, (unknown), Basima A. Almomani, Linda Tahaineh, Khawla Nuseir, Areej Othman, Kofi Boamah Mensah	15
8	Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study 2021 ·Breast Cancer Targets and Therapy ·Nehad M. Ayoub, (unknown), (unknown), Samir Al Bashir, Rami J. Yaghan	0
9	Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels 2020 ·Investigational New Drugs ·Nehad M. Ayoub, (unknown), Amer E. Alkhalifa, Belal Al‐Husein	15
10	The Role of Establishing a Multidisciplinary Team for Idiopathic Granulomatous Mastitis in Improving Patient Outcomes and Spreading Awareness about Recent Disease Trends 2020 ·International Journal of Breast Cancer ·Rami J. Yaghan, Nehad M. Ayoub, Shadi Hamouri, (unknown), (unknown), (unknown), (unknown), (unknown), Nabil A. Al-Zoubi	9
11	Management of Sickle Cell Disease Pain among Adolescent and Pediatric Patients 2019 ·Brain Sciences ·(unknown), Khawla Nuseir, Ahmad Altarifi, (unknown), Nehad M. Ayoub, (unknown)	5
12	Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches 2019 ·Breast Cancer Targets and Therapy ·Nehad M. Ayoub, Kamal M. Al-Shami, Rami J. Yaghan	73
13	Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents 2017 ·OncoTargets and Therapy ·Nehad M. Ayoub, Kamal M. Al-Shami, Mohammad A. Y. Alqudah, Nizar M. Mhaidat	29
14	The olive oil phenolic (-)-oleocanthal modulates estrogen receptor expression in luminal breast cancer in vitro and in vivo and synergizes with tamoxifen treatment 2017 ·European Journal of Pharmacology ·Nehad M. Ayoub, Abu Bakar Siddique, Hassan Y. Ebrahim, Mohamed M. Mohyeldin, Khalid A. El Sayed	59
15	Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: A descriptive study from Jordan 2016 ·Pharmacy Practice ·Tareq L. Mukattash, Wail Hayajneh, (unknown), (unknown), Nehad M. Ayoub, (unknown), Maher Khdour, Ammar Almaaytah	19
16	Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects 2016 ·Biomedical Reports ·Mohammad J. Alkhatatbeh, Nehad M. Ayoub, Nizar M. Mhaidat, (unknown), Lisa F. Lincz	11
17	Tumor Cell Transformation Using Antisense Oligonucleotide 2014 ·Methods in molecular biology ·Mohamed R. Akl, Nehad M. Ayoub	1
18	Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines 2012 ·Fitoterapia ·Mohamed R. Akl, Nehad M. Ayoub, Bilal Abuasal, Amal Kaddoumi, Paul W. Sylvester	41
19	γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells 2011 ·Cell Proliferation ·Nehad M. Ayoub, Sunitha V. Bachawal, Paul W. Sylvester	25
20	Influence of dietary intake of dairy products on dysmenorrhea 2010 ·Journal of obstetrics and gynaecology research ·Khalid K. Abdul‐Razzak, Nehad M. Ayoub, (unknown), Bayan A. Obeidat	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact